Conversely, reduced or absent expression of FMRP in tumor cells leads to the secretion of pro-inflammatory factors, including CCL7, CCL9, CXCL9, and CXCL10, which recruits more cytotoxic CD8 T cells and enhances the anti-tumor response of lymphocytes 157. The gene discussed is CXCL9; the disease is neoplasm.